SOLICITATION NOTICE
B -- Production of AuNP for drug delivery to the CNS to monitor efficacy and safety
- Notice Date
- 8/17/2022 9:34:39 AM
- Notice Type
- Presolicitation
- NAICS
- 541713
— Research and Development in Nanotechnology
- Contracting Office
- FDA CENTER FOR DRUG EVALUATION AND RESEARCH Silver Spring MD 20993 USA
- ZIP Code
- 20993
- Solicitation Number
- FDASB221257525
- Response Due
- 8/24/2022 7:00:00 AM
- Point of Contact
- Telisha WIlson
- E-Mail Address
-
telisha.wilson@fda.hhs.gov
(telisha.wilson@fda.hhs.gov)
- Small Business Set-Aside
- SBA Total Small Business Set-Aside (FAR 19.5)
- Description
- Production of AuNP for drug delivery to the CNS to monitor efficacy and safety
- Web Link
-
SAM.gov Permalink
(https://sam.gov/opp/0f2d46e9a67c447087512f88f19ad711/view)
- Record
- SN06430361-F 20220819/220817230124 (samdaily.us)
- Source
-
SAM.gov Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's SAM Daily Index Page |